Demystifying Drug-Drug Interactions for COVID...

How should our neurology clinics be fully prepared to integrate amyloid-targeting therapies (ATTs) into everyday, real-world practice? Credit available for this activity expires: 10/26/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/euro ...  Show more

Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM. Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscap ...  Show more

How do cannabinoids work in the body? Drs Gidal and Vandrey discuss all you need to know about cannabinoid and cannabinoid products. Credit available for this activity expires: 3/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989823? ...  Show more

In this Journal Jam podcast we dig deep into the science of FDA-approved outpatient medications for COVID with 3 critical appraisal masters: Dr. Andrew Morris, Dr. Rohit Mohindra and Dr. Justin Morgenstern. What is the evidence for the neutralizing monoclonal antibody medications ...  Show more

As medical professionals search for new treatments to help Covid-19 patients, some researchers are taking a second look at drugs that have already been approved by the FDA. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to Dr. David Fajgenbaum about repurposing old drugs ...  Show more